How to Approach an Increasingly Challenging and Subjective Japanese Pricing Environment L.E.K. Consulting Read more
Related Practice Life Sciences & Pharma Japan remains on balance an attractive pharmaceutical market, with favorable volume dynamics, generally attractive pricing and broad and unfettered market access. 01022024160129
Video / Webinar Biotech and Pharmaceuticals Pharma's Big Shift: From Doctors to Payers Providers and Patients July 25, 2024
Podcast Life Sciences & Pharma A New Generation of Drug Therapies Requires New Business Strategies July 10, 2024
Published Articles Sustainability To Meet Decarbonization Targets, Master The Circular Economy July 9, 2024
Published Articles Marketing & Sales How Can Businesses Survive the ‘Cookie Apocalypse’? April 25, 2024
Article Life Sciences & Pharma The New Map – Shifting geographic priorities for healthcare companies operating in Asia November 1, 2023